Standard BioTools Saham

Standard BioTools EPS

Laba per Saham (EPS) dari Standard BioTools (LAB) pada 13 Agu 2026 adalah -0,19 USD. Tahun sebelumnya, Laba per Saham (EPS) adalah -0,37 USD — perubahan sebesar -47,54% (lebih tinggi).

EPS

-0,19USD

YoY

-47,54%

Terakhir Diperbarui:

Laba per Saham (EPS) dari Standard BioTools adalah 2026 -0,19 USD. Laba per Saham (EPS) dari Standard BioTools adalah 2025 -0,37 USD. Menurun -47,54% lebih tinggi dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Standard BioTools Analisis saham

Apa yang dilakukan Standard BioTools? Fluidigm Corp is a biotechnology company specializing in innovative devices and solutions for DNA sequencing. The company was founded in 1999 in San Francisco and is currently headquartered in South San Francisco. It developed the Microfluidic Technology-Sensor, which allows for handling tiny amounts of fluids in a small space. This technology has enabled researchers to analyze complex samples and collect data with high accuracy. The company operates in two main segments: Analytical Instruments and Sample Preparation. In the Analytical Instruments segment, Fluidigm offers various devices suitable for DNA sequencing, including the Juno, C1, and Biomark platforms. It also provides a wide range of consumables to facilitate sample preparation. The Sample Preparation segment offers products and services to prepare and process samples for analysis, including microfluidic technology chips and modules, single-cell sequencing systems, and products for next-generation sequencing. Fluidigm serves customers in various industries, such as genomics research, cancer research, and medical fields, with a strong presence in North America, Europe, and Asia. The company is known for its continuous investment in research and development, as well as its innovative technologies and patents. Overall, Fluidigm's Microfluidic technology platform allows researchers to collect data in a small space with high accuracy. With a diversified portfolio of products and services, the company is well-positioned to continue growing and expanding its market presence in the coming years. Standard BioTools adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Standard BioTools

Laba per Saham (EPS) Standard BioTools adalah -0,19 USD pada tahun 2026.

Laba per Saham (EPS) dari Standard BioTools berubah dari -0,37 USD menjadi -0,19 USD, mewakili perubahan -47,54%. Nilainya lebih tinggi daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Laba per Saham (EPS) Standard BioTools sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Laba per Saham mengukur porsi laba perusahaan yang dialokasikan untuk setiap saham yang beredar. Metrik ini adalah metrik kunci untuk menilai profitabilitas perusahaan berdasarkan per saham.

EPS = Laba Bersih / Saham yang Beredar

Access this data via the Eulerpool API

Laporan Laba Rugi — Standard BioTools

Semua Metrik Kunci — Standard BioTools